Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.
Saved in:
| Title: | Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region. |
|---|---|
| Authors: | Nieder C; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway. carsten.nieder@nlsh.no.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway. carsten.nieder@nlsh.no., Syed MA; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway., Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway., Pawinski A; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway., Norum J; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway.; Northern Norway Regional Health Authority Trust, 8006, Bodø, Norway. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2017 Sep; Vol. 34 (9), pp. 149. Date of Electronic Publication: 2017 Jul 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
